Clinical trial
A Non-interventional Study of the Time to Relapse of Iron Deficiency Anaemia After Standard Treatment With the Intravenous Iron Monofer® (10% Iron Isomaltoside 1000)
NCT02546154 is registered in ClinicalTrials.gov with Pharmacosmos UK Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-interventional Study of the Time to Relapse of Iron Deficiency Anaemia After Standard Treatment With the Intravenous Iron Monofer® (10% Iron Isomaltoside 1000)
- Lead sponsor
- Pharmacosmos UK Ltd
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 22, 2016
- Completion date
- December 31, 2018
- Enrollment
- 359 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
iron deficiency anaemia